Class IITerminatedVoluntary: Firm initiated
Albertsons Companies LLC: food recall H-0630-2026
Albertsons Companies LLC of Boise, ID recalled Lucerne 2% Cottage Cheese 2% Milkfat Small Curd Vitamin A Added Grade A. Net wt.24oz. Perishable and keep… Reason: Metal fragments. The potential foreign object is a hard, metal (stainless steel), curled spring. Dimensions of a similar spring measure 2.27mm in cross-sectional thickness and 25.38mm in coil width. Spring ends are not sharp but may be sharp if broken/ cut. The FDA listed it as Class II in its Enforcement Report dated Apr 1, 2026; distribution: Alaska, California, Idaho, Oregon, Washington.
Record status as published: Terminated (terminated Apr 28, 2026). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Lucerne 2% Cottage Cheese 2% Milkfat Small Curd Vitamin A Added Grade A. Net wt.24oz. Perishable and keep refrigerated. Consumer package is a plastic cup with foil lid and clear plastic lid. UPC 0 21130 07662 8. Distributed by Lucerne Foods, Inc PO Box 99, Pleasanton, CA. Product is distributed in a 6-pack case that consists of a flat cardboard tray and clear plastic film. There are no graphics on the distribution unit. The cases are broken down and product is merchandised as a single 24 oz.
- Product quantity
- 12,222 tubs (24oz. per tub)
- Reason for recall
- Metal fragments. The potential foreign object is a hard, metal (stainless steel), curled spring. Dimensions of a similar spring measure 2.27mm in cross-sectional thickness and 25.38mm in coil width. Spring ends are not sharp but may be sharp if broken/ cut.
- Codes, lots and dates on the package
- BEST BEFORE MAR 31 2026.
- Distribution pattern
- Distributed in AK, ID, CA, OR, and WA.
- Recalling firm
- Albertsons Companies LLC, Boise, ID
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Mar 16, 2026 |
| Classified by the FDA | Mar 25, 2026 |
| Published in the Enforcement Report | Apr 1, 2026 |
| Terminated | Apr 28, 2026 |
Other recalls by Albertsons Companies LLC
- H-1074-2026 · Jun 10, 2026 · Class II — Contains statement does not declare Hazelnut
- H-1073-2026 · Jun 10, 2026 · Class II — Contains statement does not declare Salmon and Walnut
- H-1072-2026 · Jun 10, 2026 · Class II — Contains statement does not declare Salmon and Walnut
- H-1071-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1070-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1069-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1068-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1067-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1066-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
- H-1065-2026 · Jun 10, 2026 · Class III — Contains statement does not declare Salmon
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0630-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.